AngioDynamics: Q4 Earnings Insights

Shares of AngioDynamics ANGO were unchanged after the company reported Q4 results.

Quarterly Results

Earnings per share fell 124.00% over the past year to ($0.06), which were in line with the estimate of ($0.06).

Revenue of $58,332,000 declined by 39.43% year over year, which missed the estimate of $64,300,000.


Earnings guidance hasn't been issued by the company for now.

AngioDynamics hasn't issued any revenue guidance for the time being.

Details Of The Call

Date: Jul 16, 2020

Time: 08:00 AM

ET Webcast URL:

Recent Stock Performance

Company's 52-week high was at $21.90

Company's 52-week low was at $7.48

Price action over last quarter: Up 7.39%

Company Profile

AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings.

Posted In: EarningsNews